BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, May 6, 2026
Home » Authors » James Etheridge

James Etheridge

Articles

ARTICLES

France Suspends Cultivation of Monsanto's GM Corn

Jan. 16, 2008
By James Etheridge
PARIS - France has suspended the cultivation of genetically modified corn, which means Monsanto's MON 810 corn, the only GM corn containing a pesticide that was authorized for commercial cultivation in the country. (BioWorld International)
Read More

Faust Signs Research Deal with Takeda for GPCRs

Jan. 9, 2008
By James Etheridge

NicOx Renews Research Deal with Pfizer in Ophthalmology

Jan. 9, 2008
By James Etheridge

NicOx Renews Research Deal with Pfizer in Ophthalmology

Jan. 9, 2008
By James Etheridge

Faust Signs Research Deal with Takeda for GPCRs

Jan. 9, 2008
By James Etheridge

BioAlliance Mulls Future As Immtech Halts Trial

Jan. 2, 2008
By James Etheridge

BioAlliance Mulls Future As Immtech Halts Trial

Jan. 2, 2008
By James Etheridge

Stallergènes And Protein'eXpert Team Up To Fight Mite Allergens

Dec. 26, 2007
By James Etheridge

Hybrigenics Completes €6M IPO On Paris Alternext Stock Market

Dec. 26, 2007
By James Etheridge

Hybrigenics Completes €6M IPO On Paris Alternext Stock Market

Dec. 26, 2007
By James Etheridge
No Abstract
Read More
View All Articles by James Etheridge

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 5, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • Auvelity

    Axsome’s Auvelity cleared for large Alzheimer’s agitation market

    BioWorld
    Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
  • Strategy compass

    Bio Korea 2026: US policy risks shift to execution framework

    BioWorld
    Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
  • Pancreas

    Sonire starts US study of cancer HIFU after $18M series A

    BioWorld
    Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing